Recently, public funds' investment stances in the Hong Kong stock market have demonstrated a blend of divergence and consensus. The divergence centers on whether the current valuations of Hong Kong stocks present immediate investment opportunities. However, there is a broad agreement on the medium-to-long-term allocation value of these stocks. Notably, southbound capital (from mainland China), risk-averse funds from the Middle East, and thematic funds are poised to converge, potentially forming a powerful investment coalition. Public funds generally concur that for navigating the future market landscape, a focus on performance-driven sectors is crucial. When it comes to specific investment directions, they advocate for a balanced strategy that combines offensive and defensive plays, with a particular emphasis on the technology and innovative pharmaceutical sectors, as well as high-dividend stocks.